Drug Type Gene editing |
Synonyms RG 1501, RG1501 |
Target |
Action modulators |
Mechanism HLA modulators(Human leukocyte antigen modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Multiple Sclerosis | Preclinical | United States | 01 Jun 2025 |





